IDEXX Labs (IDXX) Stock
NASDAQ · IDXX
511.65
Fundamentals
Market cap
$40.31B
Price / Earnings ratio
35.0x
Price / Sales ratio
8.8x
Price / Book ratio
24.7x
Return on assets
0.3%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About IDEXX Labs
IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency, and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine.
SectorHealthcare
IndustryDiagnostics & Research
Employees11,000
CEOMr. Michael G. Erickson Ph.D.
IPO DateJun 21, 1991
HeadquartersWestbrook, ME
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jonathan J. Mazelsky | Executive Chairman | 1961 |
| Mr. Andrew Emerson | Executive VP, CFO & Treasurer | 1983 |
| Mr. Michael J. Lane | Executive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology | 1968 |
| Dr. Martin Smith Ph.D. | Executive Vice President of Global Operations and R&D | 1968 |
| Mr. Michael G. Erickson Ph.D. | CEO, President & Director | 1974 |
| Mr. Bob Asmann | Senior Vice President of Global Operations | — |
| Mr. Amit Gupta | Senior VP, Chief Digital & Information Officer | — |
| Ms. Sharon E. Underberg J.D. | Executive VP, General Counsel, & Corporate Secretary | 1961 |
| Ms. Julie Godon | Senior VP & Global Marketing Officer | — |
| Mr. Michael P. Johnson | Executive VP & Chief Human Resources Officer | 1978 |
Fundamentals
Valuation
Market cap$40.31B
Price-to-sales ratio8.76
Price-to-book value24.74
Price-earnings ratio35.00
Return on Equity71.00%
Return on Sales0.32%
Return on Assets0.33%
PEG ratio2.77
Earnings Per Share
Earnings Per Share$14.33
Income Statement
Average volume482,901
EBITDA$1.56B
1 year high (52w)$769.98
1 year low (52w)$500.61
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



